Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic obstructive pulmonary disease (COPD)
Biotech
Sanofi-backed Expedition lands $115M for ph. 2 COPD trial
Expedition secured an oversubscribed $115 million series B from a line-up of big-name investors to propel its lead DPP1 inhibitor through phase 2.
Marissa Russo
Aug 5, 2026 8:00am
AstraZeneca pens $2.1B deal for challenger to Merck’s Ohtuvayre
Jul 8, 2026 5:00am
AstraZeneca’s faith in IL-33 blocker pays off with new ph. 3 win
Apr 20, 2026 7:22am
Connect’s Dupixent rival hits the mark in phase 3 eczema trial
Mar 30, 2026 9:32am
AstraZeneca’s COPD hits breathe life into class rocked by flops
Mar 27, 2026 5:58am
Sanofi backs Altesa's $75M series B to bankroll rhinovirus study
Feb 19, 2026 7:00am
